GeoVax planning offering

GeoVax Labs Inc. (OTCBB:GOVX) plans to raise more than $20 million in a follow-on. Further terms were not disclosed. GeoVax's lead vaccine is in Phase IIa testing to prevent HIV/AIDS infection. The va...